Hims & Hers Health, Inc.
HIMS
Rank in Stocks
#2914
Hims & Hers Health, Inc. operates a comprehensive digital health platform that... Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
Share Price
$28.15
Last synced: 2026-10-19
Market Cap
$6.33B
Change (1 day)
0.50%
Change (1 year)
-45.19%
Country
US
Trade Hims & Hers Health, Inc. (HIMS)
Category
Healthcare
P/E ratio for Hims & Hers Health, Inc. (HIMS)
P/E ratio as of October 2026 TTM: -45.44
According to Hims & Hers Health, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -45.44. At the end of 2023 the company had a P/E ratio of -79.13.
P/E ratio history for Hims & Hers Health, Inc. from 2019 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | -45.44 | -209.69% |
| 2024 | 41.43 | -152.35% |
| 2023 | -79.13 | 296.43% |
| 2022 | -19.96 | 75.65% |
| 2021 | -11.36 | -60.12% |
| 2020 | -28.50 | 496.75% |
| 2019 | -4.78 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| - | - |
US
|
|
| - | - |
US
|
|
| - | - |
US
|
|
| -12.98 | -71.43% |
IL
|
|
| 146.70 | -422.82% |
US
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.